Mike Piazza is probably gonna get boned in the Hall of Fame voting this year

46 Comments

Bill Shaikin has a column up today in which one of Roger Clemens’ lawyers argues for Clemens’ induction to the Hall of Fame. Shocker, I know. But apart from him, this passage piques my interest:

Clemens is one of the headline attractions in what could be the most divisive election in Hall of Fame history. The first-time candidates include Clemens, Barry Bonds, Mike Piazza and Sammy Sosa, each of whom has been linked to performance-enhancing substances.

Clemens, Bonds and Sosa’s PED resumes are pretty well-known, but Piazza has not been publicly cast into their league. The relevant data points:

  • He admitted in 2002 to using androstenedione early in his career, but andro was not banned in baseball until 2004;
  • Murray Chass has gone on an unhinged one-man crusade (see here, here, here and here), saying that since he saw that Piazza had acne on his back, he had to be a ‘roider.

That’s it. That’s the alpha and omega of Piazza being “linked” to PEDs.

I don’t know if Piazza did anything besides andro. Maybe he did. Lots of star players of his generation did. Maybe that autobiography of his that comes out next February will say so. Maybe someone with actual first-hand knowledge of it will lay the evidence out for us.

But as Hall of Fame voters sit here today, all they have is legal andro use and Murray Chass’ back acne, which has been discredited by dermatologists as any sort of dispositive evidence. I have this feeling that alone is going to be enough for a huge number of Hall of Fame voters to withhold their vote for Piazza, despite him being ridiculously, over-the-top qualified for first ballot induction.

Report: Angels sign Matt Harvey to one-year, $11 million deal

Getty Images
4 Comments

The Angels have signed pitcher Matt Harvey to a one-year contract, MLB.com’s Mark Feinsand reports. Fancred’s Jon Heyman reports that the contract is for $11 million with an additional $3 million available through performance incentives.

Harvey, 29, spent 2018 with the Mets and Reds, posting an aggregate 4.94 ERA with a 131/37 K/BB ratio in 155 innings. He started off poorly with the Mets, so they traded him to the Reds in early May. He pitched much better in Cincinnati.

Harvey should have a spot secured at the back of the Angels’ rotation, but health and performance can always change that leading up to Opening Day.